학술논문
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial
Document Type
Article
Author
Source
In ESMO Open December 2023 8(6)
Subject
Language
ISSN
2059-7029